Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIPO-202 Retreatment for Central Abdominal Bulging
NCT02397525Phase 2Unknown
- Sponsor
- Neothetics
- Start
- Mar 2015
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of salmeterol, sponsored by Neothetics. Status: unknown.
02
Drugs
salmeterol
Beyond the preview
Go deeper on NCT02397525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02397525.